Corcept Therapeutics Incorporated CORT
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +133.10%
- 1 year
- +12.26%
- Open
- 84.87
- Prev close
- 85.95
- Mkt cap
- 8.77B
- Vol
- 1.43M
- Avg vol
- 1.18M
- EPS
- 0.45
- P/E
- 180.27
- Div yield
- 0.00%
More statistics
- Low
- 80.28
- High
- 85.31
- Forward P/E
- 19.33
- Beta
- 0.40
- Short ratio
- 5.51
- Inst. own
- 77.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 112.78
- 200-d avg
- 74.55
- 1y target
- 141.00
5D chart
Signals (158)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:45 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:35 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 3:20 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 3:15 PM | 1 day ago |
| SMA: Bearish | Oct 30, 3:00 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:55 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:50 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:25 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 2:20 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 2:15 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 2:10 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 2:05 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:25 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:15 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:10 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:00 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:35 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 11:00 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:55 AM | 2 days ago |
| RSI: Oversold | Oct 30, 10:15 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:55 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:45 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:45 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:40 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:30 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:10 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:05 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:05 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:00 PM | 2 days ago |
| RSI: Oversold | Oct 29, 2:10 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:45 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:40 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:40 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:35 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:30 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:25 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:25 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:10 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:50 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:45 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:30 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:45 PM | 3 days ago |
| RSI: Oversold | Oct 28, 3:35 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:50 PM | 3 days ago |
| RSI: Oversold | Oct 28, 2:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:55 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:15 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:05 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:20 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:15 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:55 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:50 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:40 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:35 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:25 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:25 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:05 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:05 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:45 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:45 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:40 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:40 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 2:45 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:35 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:35 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:35 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:05 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:45 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:30 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:10 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:00 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:25 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:05 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:20 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:15 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:15 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:10 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:30 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:10 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 2:40 PM | 5 days ago |
| RSI: Oversold | Oct 26, 2:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 1:50 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:25 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:10 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:05 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:00 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:45 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:40 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:15 PM | 6 days ago |
| SMA: Bearish | Oct 26, 10:25 AM | 6 days ago |
News
6 days ago benzinga.com
Corcept Reports Favorable Survival and Response Data in Ovarian Cancer Study
Corcept Therapeutics reported positive Phase 2 BELLA trial data for Lifyorli and chemotherapy in platinum-resistant ovarian cancer patients.
-
6 days ago benzinga.com
Corcept Therapeutics Announces Results From Part A Of Its Phase 2 BELLA Trial Of Lifyorli In Combination With Nab-Paclitaxel And Bevacizumab In Patients With Ovarian Cancer; Lifyorli In Combination With Nab-Paclitaxel And Bevacizumab Demonstrated Clinically Meaningful Progression-Free Survival, Objective Response Rate And Overall Survival
Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic…
6 days ago businesswire.com
Corcept Reports Positive Results from Phase 2 BELLA Trial of Lifyorli® Combined with Nab-Paclitaxel and Bevacizumab in Patients with Platinum-Resistant Ovarian Cancer
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe…
1 week ago benzinga.com
Oil Tops $100 on Iran Fears, Energy ETF XLE Hits New Record: Stock Market Today
WTI crude rose above $100 on fears of renewed U.S. strikes on Iran, lifting XLE to a record while staples, telecoms and the Dow slipped at midday Friday.
1 week ago gurufocus.com
2026 ADA/EASD Consensus Report Recommends Screening for Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinolo
1 week ago businesswire.com
2026 ADA/EASD Consensus Report Recommends Screening for Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe…
1 week ago zacks.com
Can Lifyorli Aid Corcept's Long-Term Growth Prospects Beyond Korlym?
CORT banks on newly approved drug, Lifyorli, while potential new approvals and clinical studies could help diversify revenues beyond Korlym.
1 week ago defenseworld.net
Corcept Therapeutics (NASDAQ:CORT) Director Sells $1,148,100.00 in Stock
Corcept Therapeutics Incorporated (NASDAQ: CORT - Get Free Report) Director James Wilson sold 10,000 shares of the company's stock in a transaction dated Thursday, October 15th. The shares were sold…
2 weeks ago defenseworld.net
Corcept Therapeutics Incorporated $CORT Stock Holdings Cut by First Citizens Bank & Trust Co.
First Citizens Bank and Trust Co. trimmed its holdings in Corcept Therapeutics Incorporated (NASDAQ: CORT) by 62.0% in the undefined quarter, according to its most recent disclosure with the…
2 weeks ago zacks.com
Buy 5 Top-Ranked Non-Tech Nasdaq Stocks to Maximize Q4 Gains
ROST, ROKU, APA, CORT and HALO are five non-tech Nasdaq stocks riding strong growth trends and rising earnings estimates, positioning them for potential gains in Q4.
2 weeks ago zacks.com
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.
2 weeks ago defenseworld.net
Corcept Therapeutics Incorporated (NASDAQ:CORT) Stock Has Consensus Target Price of $138.17 According to Analysts
Shares of Corcept Therapeutics Incorporated (NASDAQ: CORT - Get Free Report) have been given an average rating of "Moderate Buy" by the eight research firms that are covering the company,…
3 weeks ago defenseworld.net
Analyzing Xeris Biopharma (NASDAQ:XERS) and Corcept Therapeutics (NASDAQ:CORT)
Xeris Biopharma (NASDAQ: XERS - Get Free Report) and Corcept Therapeutics (NASDAQ: CORT - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two…
1 month ago zacks.com
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike
ABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility persist.
1 month ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
1 month ago businesswire.com
Corcept Announces Planned Leadership Transition
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe…
1 month ago zacks.com
CHMP Backs CORT's Lifyorli Combo in Platinum-Resistant Ovarian Cancer
Corcept's Lifyorli plus nab-paclitaxel wins a positive CHMP opinion for platinum-resistant ovarian cancer, with an EC decision expected in Q4 2026.
1 month ago defenseworld.net
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells $29,842.72 in Stock
Corcept Therapeutics Incorporated (NASDAQ: CORT - Get Free Report) insider Roberto Vieira sold 296 shares of the firm's stock in a transaction dated Wednesday, September 16th. The shares were sold at…
-
1 month ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Corcept Therapeutics, Maintains $165 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintains $165 price target.
1 month ago businesswire.com
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe…
1 month ago benzinga.com
Here’s How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 10 Years
Corcept Therapeutics (NASDAQ:CORT) has outperformed the market over the past 10 years by 20.4% on an annualized basis producing an average annual return of 33.86%. Currently, Corcept Therapeutics has…
1 month ago zacks.com
Will Korlym Continue to Aid CORT's Growth Through the Rest of 2026?
Corcept's Korlym sales rise 6.2% in H1 2026 as demand grows, while Lifyorli's launch offers a path to diversify revenues.
1 month ago fxempire.com
Corcept Grows to Mid-Cap on Institutional Support
Institutions keep buying Corcept Therapeutics Incorporated (CORT) shares in big volumes, sending them up 1,016% since 2017 and on the cusp of joining the S&P MidCap 400 index.
1 month ago fool.com
Which Is the Better Healthcare ETF: Fidelity's Low-Cost FHLC or First Trust's High-Conviction FBT?
One fund offers broad sector exposure at 0.08% cost; the other concentrates on 30 biotech stocks with higher volatility but stronger recent returns.
1 month ago seekingalpha.com
Corcept: Not Cheap, But Backed By Real Structural Growth
Corcept Therapeutics is evolving into a multi-engine growth platform, driven by expanding Cushing's and a rapid oncology ramp with Lifyorli. CORT delivered strong 2Q26 results: $256.1M revenue (+32%…
2 months ago defenseworld.net
Bank of America Corp DE Grows Holdings in Corcept Therapeutics Incorporated $CORT
Bank of America Corp DE raised its stake in Corcept Therapeutics Incorporated (NASDAQ: CORT) by 33.6% during the first quarter, according to the company in its most recent 13F filing with the SEC.…
-
3 months ago benzinga.com
Piper Sandler Reiterates Overweight on Corcept Therapeutics, Raises Price Target to $165
Piper Sandler analyst David Amsellem reiterates Corcept Therapeutics (NASDAQ:CORT) with a Overweight and raises the price target from $88 to $165.
3 months ago benzinga.com
Stock Market Today: Microsoft Ignites Chip Rebound as SanDisk Jumps 24%
Microsoft's 43% cloud growth revived the AI trade and lifted chipmakers, but Meta's guidance miss and a 19-year high in 30-year yields capped the rebound.
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session. GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap…
-
3 months ago benzinga.com
Canaccord Genuity Maintains Buy on Corcept Therapeutics, Raises Price Target to $161
Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises the price target from $150 to $161.
3 months ago benzinga.com
Lam Research, Xerox, FormFactor, Microsoft And Other Big Stocks Moving Higher On Thursday
Dow Jones index gained 300 points, Lam Research Corp rose 20.1% after reporting strong financial results. Xerox, Columbus McKinnon, and other stocks recorded gains.
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session. GlucoTrack (NASDAQ:GCTK) stock increased by 47.36% to $0.42. The market value of their outstanding…
-
3 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on Corcept Therapeutics, Raises Price Target to $165
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises the price target from $95 to $165.
-
3 months ago benzinga.com
Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares jumped 7.8% in pre-market trading.
3 months ago benzinga.com
Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know
Corcept Therapeutics shares soared 21.95% after hours as strong quarterly results and raised guidance boosted investor confidence.
3 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market session. Onconetix (NASDAQ:ONCO) shares moved upwards by 27.46% to $0.96. The company's market cap stands at…
-
3 months ago benzinga.com
Corcept Therapeutics Raises FY2026 Sales Guidance from $950.000M-$1.050B to $1.100B-$1.200B vs $1.008B Est
Corcept Therapeutics (NASDAQ:CORT) raises FY2026 sales outlook from $950.000 million-$1.050 billion to $1.100 billion-$1.200 billion vs $1.008 billion estimate.
-
3 months ago benzinga.com
Corcept Therapeutics Q2 EPS $0.36 Beats $(0.00) Estimate, Sales $256.147M Beat $219.988M Estimate
Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $(0.00) by Infinity percent. This is a 24.14 percent increase over…
-
3 months ago benzinga.com
Canaccord Genuity Maintains Buy on Corcept Therapeutics, Raises Price Target to $150
Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises the price target from $135 to $150.
3 months ago benzinga.com
This Warner Bros Discovery Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday
Top Wall Street analysts changed outlook on several top stocks. See all changes on analyst ratings page.
-
3 months ago benzinga.com
Wolfe Research Downgrades Corcept Therapeutics to Underperform, Announces $50 Price Target
Wolfe Research analyst Kalpit Patel downgrades Corcept Therapeutics (NASDAQ:CORT) from Peer Perform to Underperform and announces $50 price target.
4 months ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
-
4 months ago benzinga.com
7 Health Care Stocks With Whale Alerts In Today's Session
7 Health Care Stocks With Whale Alerts In Today's Session
5 months ago benzinga.com
Micron To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed outlook on top names. See all analyst rating changes, including upgrades/downgrades, on Benzinga's page.
6 months ago benzinga.com
Packaging Corp Of America To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
Needham analyst Rick Patel maintained a Buy rating. Steven Madden shares closed at $47.27 on Friday. Top analysts change outlook on BTSG, CELC, ESS, CORT, PKG, PRU, RVTY, and SHOO. See how they rate…
6 months ago benzinga.com
Earnings Scheduled For April 30, 2026
Earnings Scheduled For April 30, 2026
7 months ago benzinga.com
Amazon To Rally Around 49%? Here Are 10 Top Analyst Forecasts For Wednesday
Top analysts change outlook for top names. Citigroup, Tigress Fin, Piper Sandler, Morgan Stanley, HC Wainwright, Susquehanna, Raymond James and Goldman Sachs adjust price targets for companies like…
7 months ago benzinga.com
AAR Foods Posts Upbeat Q3 Earnings, Joins Braze, Arm Holdings And Other Big Stocks Moving Higher On Wednesday
U.S. stocks rose, with the Dow Jones gaining 350 points on Wednesday. AAR Corp (NYSE: AIR) saw a 10.5% jump in shares after reporting strong earnings and raising its sales forecast.
7 months ago benzinga.com
Dow Surges Over 300 Points; Chewy Shares Jump On Upbeat Earnings
US stocks rise with the Dow gaining over 300 points. Chewy shares jump 14%. Sarepta Therapeutics surges 29%. Oil down 2.1%, gold up 3.2%.
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session